Skip to Main Content

Author Details

William T Abraham
The Ohio State University
1990
580
108
PMIDPaper TitleJournal TitlePublished Year
37671601Comorbidities and clinical response to cardiac resynchronization therapy: Patient-level meta-analysis from eight clinical trials.Eur J Heart Fail2024
37984672Benefit of cardiac resynchronization therapy among older patients: A patient-level meta-analysis.Am Heart J2024
36321445Enhancing Sweat Rate Using a Novel Device for the Treatment of Congestion in Heart Failure.Circ Heart Fail2023
37522254Cardiac resynchronization therapy in patients with a prior history of atrial fibrillation: Insights from four major clinical trials.J Cardiovasc Electrophysiol2023
37782695Standardized Definitions for Cardiogenic Shock Research and Mechanical Circulatory Support Devices: Scientific Expert Panel From the Shock Academic Research Consortium (SHARC).Circulation2023
37646214Changes in Left Ventricular Global Longitudinal Strain in Patients With Heart Failure and Secondary Mitral Regurgitation: The COAPT Trial.J Am Heart Assoc2023
35633055Hypertensive events after the initiation of contemporary cancer therapies for breast cancer control.Cancer Med2023
37461448Outcomes of Cardiac Resynchronization Therapy by New York Heart Association Class: A Patient-Level Meta-Analysis.medRxiv2023
37461163Patient phenotype profiling in heart failure with preserved ejection fraction to guide therapeutic decision making. A scientific statement of the Heart Failure Association, the European Heart Rhythm Association of the European Society of Cardiology, and the European Society of Hypertension.Eur J Heart Fail2023
37210750Efficacy of pulmonary artery pressure monitoring in patients with chronic heart failure: a meta-analysis of three randomized controlled trials.Eur Heart J2023
37115135Guideline-Directed Medical Therapy Tolerability in Patients With Heart Failure and Mitral Regurgitation: The COAPT Trial.JACC Heart Fail2023
37380226Cerebrovascular Events After Transcatheter Edge-to-Edge Repair and Guideline-Directed Medical Therapy in the COAPT Trial.JACC Cardiovasc Interv2023
37306651Impact of Malnutrition in Patients With Heart Failure and Secondary Mitral Regurgitation: The COAPT Trial.J Am Coll Cardiol2023
37369637Knowledge about self-efficacy and outcomes in patients with heart failure and reduced ejection fraction.Eur J Heart Fail2023
37401511Impact of comorbidities on health status measured using the Kansas City Cardiomyopathy Questionnaire in patients with heart failure with reduced and preserved ejection fraction.Eur J Heart Fail2023
37366061Clinical Characteristics and Outcomes in Patients With Heart Failure: Are There Thresholds and Inflection Points in Left Ventricular Ejection Fraction and Thresholds Justifying a Clinical Classification?Circulation2023
37358785Stroke in patients with heart failure and reduced or preserved ejection fraction.Eur Heart J2023
37225286Ventricular Remodeling and Outcomes After Mitral Transcatheter Edge-to-Edge Repair in Heart Failure: The COAPT Trial.JACC Cardiovasc Interv2023
37194288Transcatheter Mitral Valve Replacement Versus Medical Therapy for Secondary Mitral Regurgitation: A Propensity Score-Matched Comparison.Circ Cardiovasc Interv2023
37092287Safety, usability, and performance of a wireless left atrial pressure monitoring system in patients with heart failure: the VECTOR-HF trial.Eur J Heart Fail2023
37062869Impact of multimorbidity on mortality in heart failure with reduced ejection fraction: which comorbidities matter most? An analysis of PARADIGM-HF and ATMOSPHERE.Eur J Heart Fail2023
36752227Impact of Peripheral Artery Disease in Patients With Heart Failure Undergoing Transcatheter Mitral Valve Repair: The COAPT Trial.J Am Heart Assoc2023
36876756Five-Year Follow-up after Transcatheter Repair of Secondary Mitral Regurgitation.N Engl J Med2023
36809039A Composite Score Summarizing Use and Dosing of Evidence-Based Medical Therapies in Heart Failure: A Nationwide Cohort Study.Circ Heart Fail2023
36823954Association between serum albumin and outcomes in heart failure and secondary mitral regurgitation: the COAPT trial.Eur J Heart Fail2023
36861266Transcatheter interventions for heart failure.EuroIntervention2023
36700426Cardiac Resynchronization Therapy Improves Outcomes in Patients With Intraventricular Conduction Delay But Not Right Bundle Branch Block: A Patient-Level Meta-Analysis of Randomized Controlled Trials.Circulation2023
34843964The importance of early evaluation after cardiac resynchronization therapy to redefine response: Pooled individual patient analysis from 5 prospective studies.Heart Rhythm2022
35411329Cardiac Pulmonary Nerve Stimulation (CPNS<sup>TM</sup>): A Novel Treatment for Acute Decompensated Heart Failure.JACC Basic Transl Sci2022
35791663Guideline-directed medical therapy in patients undergoing transcatheter edge-to-edge repair for secondary mitral regurgitation.Eur J Heart Fail2022
35780032Minimally Clinically Important Difference in Health Status Scores in Patients With HFrEF vs HFpEF.JACC Heart Fail2022
35713888Baroreflex activation therapy with the Barostimâ¿¢ device in patients with heart failure with reduced ejection fraction: a patient level meta-analysis of randomized controlled trials.Eur J Heart Fail2022
35654526Clinical Outcomes Related to Background Diuretic Use and New Diuretic Initiation in Patients With HFrEF.JACC Heart Fail2022
35587824Changes in voice patterns for monitoring heart failure deterioration.EuroIntervention2022
36456063Functional and Symptomatic Clinical Trial Endpoints: The HFC-ARC Scientific Expert Panel.JACC Heart Fail2022
35973560Development of a New Technique for Ultrasound Imaging of the Innominate Vein and the Venous Angle.J Am Soc Echocardiogr2022
36202557Prediction of Death or HF Hospitalization in Patients With Severe FMR: The COAPT Risk Score.JACC Cardiovasc Interv2022
36357085Hospitalizations and Mortality in Patients With Secondary Mitral Regurgitation and Heart Failure: The COAPT Trial.J Am Coll Cardiol2022
36265184Prognostic implications of mitral valve geometry in patients with secondary mitral regurgitation: the COAPT trial.Eur Heart J Cardiovasc Imaging2022
36029463Aptamer Proteomics for Biomarker Discovery in Heart Failure With Reduced Ejection Fraction.Circulation2022
36017729Predicting stroke in heart failure and reduced ejection fraction without atrial fibrillation.Eur Heart J2022
35041933The V-LAP System for Remote Left Atrial Pressure Monitoring of Patients With Heart Failure: Remote Left Atrial Pressure Monitoring.J Card Fail2022
35093278Age-Related Outcomes After Transcatheter Mitral Valve Repair in Patients With Heart Failure: Analysis From COAPT.JACC Cardiovasc Interv2022
34969496Remote Speech Analysis in the Evaluation of Hospitalized Patients With Acute Decompensated Heart Failure.JACC Heart Fail2022
35115106Optimal Background Pharmacological Therapy for Heart Failure Patients in Clinical Trials: JACC Review Topic of the Week.J Am Coll Cardiol2022
35134897Impact of baseline renal dysfunction on cardiac outcomes and end-stage renal disease in heart failure patients with mitral regurgitation: the COAPT trial.Eur Heart J2022
33351892Effect of empagliflozin on exercise ability and symptoms in heart failure patients with reduced and preserved ejection fraction, with and without type 2 diabetes.Eur Heart J2021
33719505Implications of Atrial Fibrillation on the Mechanisms of Mitral Regurgitation and Response to MitraClip in the COAPT Trial.Circ Cardiovasc Interv2021
33626889Remote Hemodynamic-Guided Therapy of Patients With Recurrent Heart Failure Following Cardiac Resynchronization Therapy.J Am Heart Assoc2021
33621540Natriuretic peptide plasma concentrations and risk of cardiovascular versus non-cardiovascular events in heart failure with reduced ejection fraction: Insights from the PARADIGM-HF and ATMOSPHERE trials.Am Heart J2021
  • 1 - 50 of 580

Recommended Authors

Veraprapas Kittipibul
Duke University Medical Center, NC Duke Clinical Research Institute
Career Start Year 2017
Number of shared co-authors 5
Mohammad Al-Ani
University of Florida Gainesville
Career Start Year 2015
Number of shared co-authors 1
Niyada Naksuk
University of Nebraska Medical Center, 9882265 Nebraska Medical Center
Career Start Year 2013
Number of shared co-authors 2
Daniel A Steinhaus
University of Missouri-Kansas City, Saint Luke's Mid America Heart Institute
Career Start Year 2012
Number of shared co-authors 1
Auras R Atreya
AIG Hospitals Institute of Cardiac Sciences and Research
Career Start Year 2011
Number of shared co-authors 0
Mustafa M Ahmed
University of Florida
Career Start Year 2011
Number of shared co-authors 2
Andrew N Rosenbaum
Mayo Clinic
Career Start Year 2011
Number of shared co-authors 4
Adam D DeVore
Duke University School of Medicine, NC Duke Clinical Research Institute
Career Start Year 2010
Number of shared co-authors 26
Konstantinos C Siontis
Mayo Clinic
Career Start Year 2010
Number of shared co-authors 4
Alex M Parker
University of Florida
Career Start Year 2009
Number of shared co-authors 4
Hind Rahmouni
Knight Cardiovascular Institute, Oregon Health and Science University
Career Start Year 2006
Number of shared co-authors 0
Jason N Katz
Duke University Medical Center.
Career Start Year 2005
Number of shared co-authors 22
Ravi V Desai
Gladstone Institutes
Career Start Year 2004
Number of shared co-authors 4
Joseph G Akar
Center for Outcomes Research and Evaluation, Yale-New Haven Hospital
Career Start Year 2001
Number of shared co-authors 4
Kevin J Anstrom
University of North Carolina at Chapel Hill
Career Start Year 1999
Number of shared co-authors 33
Robert L McNamara
Yale University School of Medicine
Career Start Year 1997
Number of shared co-authors 12
Naveen L Pereira
Mayo Clinic
Career Start Year 1997
Number of shared co-authors 7
Chetan B Patel
Duke University Hospital
Career Start Year 1997
Number of shared co-authors 18
Andrew D Michaels
NYCHHC/Elmhurst Hospital Center
Career Start Year 1996
Number of shared co-authors 9
Peter A Brady
Mayo Clinic
Career Start Year 1995
Number of shared co-authors 4
Frederick A Masoudi
University of Colorado School of Medicine
Career Start Year 1994
Number of shared co-authors 34
Andrea M Russo
Duke University Medical Center
Career Start Year 1992
Number of shared co-authors 15
Paul A Heidenreich
Stanford University School of Medicine
Career Start Year 1989
Number of shared co-authors 37
Stuart D Katz
NYU Grossman School of Medicine
Career Start Year 1988
Number of shared co-authors 14
Kenneth B Margulies
Perelman School of Medicine at the University of Pennsylvania
Career Start Year 1988
Number of shared co-authors 17
Shawn W Robinson
University of Maryland
Career Start Year 1986
Number of shared co-authors 0
Pamela S Douglas
Duke Clinical Research Institute, Duke University
Career Start Year 1984
Number of shared co-authors 25
Ulf Dahlstr??m
Linkoping University
Career Start Year 1977
Number of shared co-authors 24
Christiane E Angermann
University and University Hospital Wurzburg
Career Start Year 1976
Number of shared co-authors 13
Georg Ertl
University Hospital Wurzburg
Career Start Year 1974
Number of shared co-authors 19

Collaborators

JoAnn Lindenfeld
Vanderbilt University Medical Center
Co-authored papers 71
Gregg C Fonarow
David Geffen School of Medicine, University of California, Los Angeles Medical Center
Co-authored papers 40
Mihai Gheorghiade
Bluhm Cardiovascular Institute, Northwestern University Feingerg School of Medicine
Co-authored papers 34
Kenneth Dickstein
University of Bergen
Co-authored papers 32
Akshay S Desai
Brigham and Women's Hospital, Harvard Medical School
Co-authored papers 26
Milton Packer
Co-authored papers 23
Alan S Maisel
University of California
Co-authored papers 23
Alan B Storrow
Vanderbilt University Medical Center
Co-authored papers 23
Judd E Hollander
Sidney Kimmel Medical College, Thomas Jefferson University
Co-authored papers 22
Peter A McCullough
Truth for Health Foundation
Co-authored papers 20
James McCord
Heart and Vascular Institute
Co-authored papers 20
Richard Nowak
Henry Ford Hospital System
Co-authored papers 19
Gerasimos Filippatos
National and Kapodistrian University of Athens, Attikon University Hospital
Co-authored papers 18
Barry M Massie
University of California at San Francisco
Co-authored papers 18
John G F Cleland
British Heart Foundation Centre of Research Excellence, University of Glasgow
Co-authored papers 16
Alan H B Wu
University of California san francisco
Co-authored papers 15
David J Cohen
Clinical Trials Center, Cardiovascular Research Foundation
Co-authored papers 15
Paul Clopton
Department of Medicine and Cardiovascular Institute, Stanford University
Co-authored papers 14
John R Teerlink
Cardiology University of California San Francisco (UCSF)
Co-authored papers 11
Juan M Aranda
University of Florida
Co-authored papers 11
Mark F Aaron
Saint Thomas West Hospital
Co-authored papers 10
William F Peacock
Baylor College of Medicine
Co-authored papers 10
Fred A Weaver
Keck Medical Center of University of Southern California
Co-authored papers 9
Lynne E Wagoner
The Heart Institute, Mercy Hospital
Co-authored papers 9
Mariell Jessup
University of Pennsylvania Perelman School of Medicine
Co-authored papers 9
Ayesha Hasan
The Ohio State University Wexner Medical Center
Co-authored papers 9
Brian C Hiestand
Wake Forest School of Medicine
Co-authored papers 8
Sean P Collins
Vanderbilt University School of Medicine
Co-authored papers 8
Norman Stockbridge
Center for Drug Evaluation and Research
Co-authored papers 7
Jonathan P Piccini
Duke University, NC Duke Clinical Research Institute
Co-authored papers 7
Release 1.2